Table of Content
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS AND EXCLUSIONS
1.4 MARKET SCOPE
1.4.1 MARKET SEGMENTATION
1.4.2 REGIONAL SCOPE
1.5 YEARS CONSIDERED
1.6 CURRENCY CONSIDERED
1.7 STAKEHOLDERS
1.8 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 SECONDARY DATA
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.3 PRIMARY DATA
2.3.1 KEY DATA FROM PRIMARY SOURCES
2.3.2 KEY INDUSTRY INSIGHTS
2.3.3 BREAKDOWN OF PRIMARY INTERVIEWS
2.4 MARKET SIZE ESTIMATION
2.5 MARKET SHARE ANALYSIS
2.6 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.1 DIGITAL HEALTH MARKET ANALYSIS THROUGH PRIMARY INTERVIEWS
2.7 RESEARCH ASSUMPTIONS
2.8 RISK ASSESSMENT
2.9 LIMITATIONS
2.1 IMPACT OF RECESSION ON DIGITAL HEALTH MARKET
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 DIGITAL HEALTH MARKET: MARKET OVERVIEW
4.2 DIGITAL HEALTH MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.3 NORTH AMERICA: DIGITAL HEALTH MARKET, BY COMPONENT AND END USER
4.4 REGIONAL MIX: DIGITAL HEALTH MARKET (2021–2028)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 INDUSTRY TRENDS
5.4 TECHNOLOGY ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 BARGAINING POWER OF SUPPLIERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 PATENT ANALYSIS
5.8.1 PATENT PUBLICATION TRENDS FOR DIGITAL HEALTH
5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.9 TARIFF & REGULATORY LANDSCAPE
5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.9.2 NORTH AMERICA
5.9.2.1 US
5.9.2.2 Canada
5.9.3 EUROPE
5.9.4 ASIA PACIFIC
5.9.4.1 India
5.9.4.2 Japan
5.9.4.3 China
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY
5.11 TRENDS & DISRUPTIONS AFFECTING CUSTOMERS’ BUSINESS
5.11.1 REVENUE SHIFT & NEW REVENUE POCKETS FOR DIGITAL HEALTH MARKET
5.12 KEY CONFERENCES & EVENTS IN 2023–2024
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.13.2 BUYING CRITERIA
5.14 UNMET NEEDS – DIGITAL HEALTH MARKET
5.15 CASE STUDY ANALYSIS
5.16 ADJACENT MARKET ANALYSIS
6 DIGITAL HEALTH MARKET, BY OFFERING, 2021–2028 (USD MILLION)
6.1 INTRODUCTION
6.2 HARDWARE
6.3 SOFTWARE
6.3.1 ANNUAL LICENSING
6.3.2 SUBSCRIPTION-BASED
6.4 SERVICES
6.4.1 SUBSCRIPTION-BASED
6.4.2 PAY-PER SERVICE (VALUE-BASED)
6.5 APPLICATIONS (ONLY PAID APPLICATIONS)
6.5.1 ONE TIME PURCHASE
6.5.2 SUBSCRIPTION-BASED
6.5.3 PAY-PER USE (VALUE-BASED)
7 DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
7.1 INTRODUCTION
7.2 MHEALTH
7.2.1 MHEALTH DEVICES
7.2.1.1 VITAL SIGN MONITORS
7.2.1.2 PEAK FLOW METERS
7.2.1.3 FETAL MONITORS
7.2.1.4 SLEEP APNEA MONITORS
7.2.1.5 NEUROLOGICAL MONITORS
7.2.1.6 OTHERS
7.2.2 MHEALTH APPS
7.2.2.1 MEDICAL APPS
7.2.2.2 FITNESS APPS
7.3 TELEHEALTHCARE
7.3.1 TELECARE
7.3.1.1 ACTIVITY MONITORING
7.3.1.2 REMOTE MEDICATION MANAGEMENT
7.3.2 TELEHEALTH
7.3.2.1 LTC MONITORING
7.3.2.2 VIDEO CONSULTATION
7.4 DIGITAL THERAPEUTICS
7.4.1 PREVENTIVE APPLICATIONS
7.4.2 TREATMENT APPLICATIONS
7.5 HEALTH MANAGEMENT SOLUTIONS
7.5.1 EHR
7.5.2 HEALTHCARE ANALYTICS
7.5.3 E-PRESCRIBING
8 DIGITAL HEALTH MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.1 INTRODUCTION
8.2 CHRONIC DISEASE MANAGEMENT
8.3 BEHAVIOURAL HEALTH
8.4 HEALTH & FITNESS
8.5 OTHERS
9 DIGITAL HEALTH MARKET, BY END USER, 2021–2028 (USD MILLION)
9.1 INTRODUCTION
9.2 PROVIDERS
9.2.1 HOSPITALS & CLINICS
9.2.3 LONG TERM CARE CENTERS & ASSISTED LIVING CENTERS
9.3 PAYERS
9.3.1 PUBLIC
9.3.2 PRIVATE
9.4 PATIENTS & CONSUMERS
10 DIGITAL HEALTH MARKET, BY REGION, 2021–2028 (USD MILLION)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 RECESSION IMPACT
10.2.2 US
10.2.3 CANADA
10.3 EUROPE
10.3.1 RECESSION IMPACT
10.3.2 GERMANY
10.3.3 UK
10.3.4 FRANCE
10.3.5 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 RECESSION IMPACT
10.4.2 JAPAN
10.4.3 CHINA
10.4.4 INDIA
10.4.5 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 RECESSION IMPACT
10.6 MIDDLE EAST AND AFRICA
10.6.1 RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
11.4 MARKET SHARE/RANKING ANALYSIS
11.5 COMPANY EVALUATION MATRIX
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT
11.6 START-UP/SME EVALUATION MATRIX
11.5.1 PROGRESSIVE COMPANIES
11.5.2 RESPONSIVE COMPANIES
11.5.3 DYNAMIC COMPANIES
11.5.4 STARTING BLOCKS
11.5.5 COMPETITIVE BENCHMARKING
11.7 COMPETITIVE SCENARIOS AND TRENDS
11.5.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
11.5.2 DEALS
11.5.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY COMPANIES
12.1.1 KONINKLIJKE PHILIPS N.V.
12.1.2 MEDTRONIC
12.1.3 GE HEALTHCARE
12.1.4 ABBOTT
12.1.5 OMRON CORPORATION
12.1.6 JOHNSON & JOHNSON PRIVATE LIMITED
12.1.7 MASIMO
12.1.8 MERATIVE
12.1.9 FITBIT, INC. (A GOOGLE COMPANY)
12.1.10 AT & T, INC.
12.1.11 NOOM, INC.
12.1.12 TELADOC HEALTH, INC.
12.1.13 OMADA HEALTH INC.
12.1.14 DEXCOM
12.1.15 SIEMENS HEALTHINEERS
12.1.16 APPLE, INC.
12.1.17 BIOTRICITY
12.1.18 VERADIGM LLC
12.2 OTHER PLAYERS
12.2.1 IHEALTH LABS, INC.
12.2.2 MY MHEALTH LIMITED
12.2.3 ATHENAHEALTH, INC.
12.2.4 ECLINICALWORKS
12.2.5 AIRSTRIP TECHNOLOGIES, INC
12.2.6 ADVANCEDMD, INC.
12.2.7 QARDIO, INC.
13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 CUSTOMIZATION OPTIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS